Search filters

List of works by Marta Coscia

A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patients.

scientific article published on 20 August 2015

Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma.

scientific article published on 26 May 2015

Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience

scientific article published on 27 January 2016

Bendamustine and subcutaneous alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients

scientific article published on 27 June 2014

CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death

scientific article published on 13 October 2011

CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib

scientific article published on 5 December 2007

Cancer immunotherapy with chemoattractant peptides.

scientific article published in June 2004

Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials.

scientific article

Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: an Italian multicentric survey.

scientific article published on 17 October 2013

Comprehensive assessment of the TCRBV repertoire in small T-cell samples by means of an improved and convenient multiplex PCR method.

scientific article

Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease.

scientific article published on 4 February 2015

Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells.

scientific article published on 29 August 2012

Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma.

scientific article published in April 2005

Exposure to myeloma cell lysates affects the immune competence of dendritic cells and favors the induction of Tr1-like regulatory T cells

scientific article published on 01 April 2005

Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia

scientific article published on 3 November 2014

Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia

scientific article published on 30 October 2013

HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism

scientific article

IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells

scientific article published on 04 March 2011

Immune Modulation by Zoledronic Acid in Human Myeloma: An Advantageous Cross-Talk between V 9V 2 T Cells, CD8+ T Cells, Regulatory T Cells, and Dendritic Cells

scientific article published on 13 July 2011

Long-term follow-up of idiotype vaccination in human myeloma as a maintenance therapy after high-dose chemotherapy

scientific article published on 01 January 2004

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia

scientific article published on 14 August 2015

Murine beta-defensin 2 promotes TLR-4/MyD88-mediated and NF-kappaB-dependent atypical death of APCs via activation of TNFR2

scientific article published on 11 January 2008

Polyclonal immunoglobulin E levels are correlated with hemoglobin values and overall survival in patients with multiple myeloma

scientific article published on September 2007

Prognostic Significance of PET/CT in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Frontline Chemoimmunotherapy

scientific article published on 03 July 2020

Retracted: Zoledronic Acid Restores Doxorubicin Chemosensitivity and Immunogenic Cell Death in Multidrug-Resistant Human Cancer Cells

retracted article

SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response

scientific article published on 30 November 2015

Severe and long-lasting disruption of T-cell receptor diversity in human myeloma after high-dose chemotherapy and autologous peripheral blood progenitor cell infusion.

scientific article

Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells.

scientific article published on 27 May 2015

The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia.

scientific article published on 8 January 2013

The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespectiveof the disease status

scientific article published on 27 June 2014

The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targeting.

scientific article published on 3 July 2014

Vγ9Vδ2 T cell-based immunotherapy in hematological malignancies: from bench to bedside.

scientific article published on 17 May 2011

Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway.

scientific article published on December 2010

Paulina is supported by:

About Paulina

Help